abstract |
The present invention relates to pyrimidine-2,4,6-trione metalloproteinase inhibitors of the formula n n n wherein X, Y, A, B and R 1 are as defined in the specification, and to pharmaceutical compositions and methods of treating inflammation, cancer and other disorders. |